184 related articles for article (PubMed ID: 21118946)
1. In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections.
Lamberton PH; Hogan SC; Kabatereine NB; Fenwick A; Webster JP
Am J Trop Med Hyg; 2010 Dec; 83(6):1340-7. PubMed ID: 21118946
[TBL] [Abstract][Full Text] [Related]
2. Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy.
Bustinduy AL; Waterhouse D; de Sousa-Figueiredo JC; Roberts SA; Atuhaire A; Van Dam GJ; Corstjens PL; Scott JT; Stanton MC; Kabatereine NB; Ward S; Hope WW; Stothard JR
mBio; 2016 Aug; 7(4):. PubMed ID: 27507822
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme.
Gower CM; Gehre F; Marques SR; Lamberton PHL; Lwambo NJ; Webster JP
Parasit Vectors; 2017 Dec; 10(1):593. PubMed ID: 29197426
[TBL] [Abstract][Full Text] [Related]
4. Regular treatments of praziquantel do not impact on the genetic make-up of Schistosoma mansoni in Northern Senegal.
Huyse T; Van den Broeck F; Jombart T; Webster BL; Diaw O; Volckaert FA; Balloux F; Rollinson D; Polman K
Infect Genet Evol; 2013 Aug; 18():100-5. PubMed ID: 23684792
[TBL] [Abstract][Full Text] [Related]
5. Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda.
Faust CL; Crotti M; Moses A; Oguttu D; Wamboko A; Adriko M; Adekanle EK; Kabatereine N; Tukahebwa EM; Norton AJ; Gower CM; Webster JP; Lamberton PHL
Parasit Vectors; 2019 Dec; 12(1):607. PubMed ID: 31881923
[TBL] [Abstract][Full Text] [Related]
6. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
Fallon PG; Doenhoff MJ
Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
[TBL] [Abstract][Full Text] [Related]
7. Laboratory induced resistance to praziquantel in experimental schistosomiasis.
Ismail MM; Taha SA; Farghaly AM; el-Azony AS
J Egypt Soc Parasitol; 1994 Dec; 24(3):685-95. PubMed ID: 7844435
[TBL] [Abstract][Full Text] [Related]
8. Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial.
Nalugwa A; Nuwaha F; Tukahebwa EM; Olsen A
PLoS Negl Trop Dis; 2015 May; 9(5):e0003796. PubMed ID: 26011733
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.
Barakat R; El Morshedy H
Parasitology; 2011 Apr; 138(4):440-6. PubMed ID: 21078223
[TBL] [Abstract][Full Text] [Related]
10. The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype.
Pinto-Almeida A; Mendes T; Armada A; Belo S; Carrilho E; Viveiros M; Afonso A
PLoS One; 2015; 10(10):e0140147. PubMed ID: 26445012
[TBL] [Abstract][Full Text] [Related]
11. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
[TBL] [Abstract][Full Text] [Related]
12. Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni.
Fallon PG; Sturrock RF; Niang AC; Doenhoff MJ
Am J Trop Med Hyg; 1995 Jul; 53(1):61-2. PubMed ID: 7625534
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic analysis of reduced sensitivity to praziquantel in Schistosoma mansoni.
Sanchez MC; Cupit PM; Bu L; Cunningham C
Mol Biochem Parasitol; 2019 Mar; 228():6-15. PubMed ID: 30658180
[TBL] [Abstract][Full Text] [Related]
14. Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure.
Sabra AN; Botros SS
J Parasitol; 2008 Apr; 94(2):537-41. PubMed ID: 18564758
[TBL] [Abstract][Full Text] [Related]
15. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel.
Ismail M; Metwally A; Farghaly A; Bruce J; Tao LF; Bennett JL
Am J Trop Med Hyg; 1996 Aug; 55(2):214-8. PubMed ID: 8780463
[TBL] [Abstract][Full Text] [Related]
16. Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential
Amara RO; Ramadan AA; El-Moslemany RM; Eissa MM; El-Azzouni MZ; El-Khordagui LK
Int J Nanomedicine; 2018; 13():4493-4505. PubMed ID: 30122922
[TBL] [Abstract][Full Text] [Related]
17. Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections.
Coeli R; Baba EH; Araujo N; Coelho PM; Oliveira G
PLoS Negl Trop Dis; 2013; 7(12):e2596. PubMed ID: 24367712
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
19. Resistance to praziquantel, effect of drug pressure and stability test.
Ismail MM; Farghaly AM; Dyab AK; Afify HA; el-Shafei MA
J Egypt Soc Parasitol; 2002 Aug; 32(2):589-600. PubMed ID: 12214936
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a method for induction of praziquantel resistance in Schistosoma mansoni.
Lotfy WM; Hishmat MG; El Nashar AS; Abu El Einin HM
Pharm Biol; 2015 Aug; 53(8):1214-9. PubMed ID: 25609146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]